Abstract:Bayesian networks (BNs) are machine-learning–based computational models that visualize causal relationships and provide insight into the processes underlying disease progression, closely resembling clinical decision-making. Preoperative identification of patients at risk for lymph node metastasis (LNM) is challenging in endometrial cancer, and although several biomarkers are related to LNM, none of them are incorporated in clinical practice. The aim of this study was to develop and externally validate a preoperative BN to predict LNM and outcome in endometrial cancer patients.Within the European Network for Individualized Treatment of Endometrial Cancer (ENITEC), we performed a retrospective multicenter cohort study including 763 patients, median age 65 years (interquartile range [IQR] 58–71), surgically treated for endometrial cancer between February 1995 and August 2013 at one of the 10 participating European hospitals. A BN was developed using score-based machine learning in addition to expert knowledge. Our main outcome measures were LNM and 5-year disease-specific survival (DSS). Preoperative clinical, histopathological, and molecular biomarkers were included in the network. External validation was performed using 2 prospective study cohorts: the Molecular Markers in Treatment in Endometrial Cancer (MoMaTEC) study cohort, including 446 Norwegian patients, median age 64 years (IQR 59–74), treated between May 2001 and 2010; and the PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study cohort, including 384 Dutch patients, median age 66 years (IQR 60–73), treated between September 2011 and December 2013. A BN called ENDORISK (preoperative risk stratification in endometrial cancer) was developed including the following predictors: preoperative tumor grade; immunohistochemical expression of estrogen receptor (ER), progesterone receptor (PR), p53, and L1 cell adhesion molecule (L1CAM); cancer antigen 125 serum level; thrombocyte count; imaging results on lymphadenopathy; and cervical cytology. In the MoMaTEC cohort, the area under the curve (AUC) was 0.82 (95% confidence interval [CI] 0.76–0.88) for LNM and 0.82 (95% CI 0.77–0.87) for 5-year DSS. In the PIPENDO cohort, the AUC for 5-year DSS was 0.84 (95% CI 0.78–0.90). The network was well-calibrated. In the MoMaTEC cohort, 249 patients (55.8%) were classified with <5% risk of LNM, with a false-negative rate of 1.6%. A limitation of the study is the use of imputation to correct for missing predictor variables in the development cohort and the retrospective study design.In this study, we illustrated how BNs can be used for individualizing clinical decision-making in oncology by incorporating easily accessible and multimodal biomarkers. The network shows the complex interactions underlying the carcinogenetic process of endometrial cancer by its graphical representation. A prospective feasibility study will be needed prior to implementation in the clinic.

Risk Stratification of Postoperative Adjuvant Therapy for Endometrial Cancer (POAT-ENDORISK) Based on Bayesian Network Model: A Development and Validation Study.

Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study

Postoperative Survival Prediction Model of BP Neural Network with Variable Cluster

Development of Asian Non-Small Cell Lung Cancer Survival Prediction Model Using an Innovative Method of Bayesian Network.

Development of a Bayesian Belief Network Model for Personalized Prognostic Risk Assessment in Colon Carcinomatosis

Optimal Bayesian Network Model for Discovering Risk Factors for Liver Metastasis in Breast Cancer

Estimating the Risk and Benefit of Radiation Therapy in (y)pN1 Stage Breast Cancer Patients: A Bayesian Network Model Incorporating Expert Knowledge (KROG 22-13)

Development and Validation of a Novel Prognostic Model for Endometrial Cancer Based on Clinical Characteristics

Analysis of Prognostic Factors of Rectal Cancer and Construction of a Prognostic Prediction Model Based on Bayesian Network

Development, Verification, and Comparison of a Risk Stratification Model Integrating Residual Cancer Burden to Predict Individual Prognosis in Early-Stage Breast Cancer Treated with Neoadjuvant Therapy.

The Usefulness of Bayesian Network in Assessing the Risk of Triple-Negative Breast Cancer.

Study of endometrial carcinoma on correlation between molecular typing and lymph node metastasis and construction of prediction model.

Development and validation of a prognostic nomogram model incorporating routine laboratory biomarkers for preoperative patients with endometrial cancer

Development and validation of a pathological model predicting the efficacy of neoadjuvant therapy for breast cancer based on RCB scoring

A Novel Prognostic Model of Endometrial Carcinoma Based on Clinical Variables and Oncogenomic Gene Signature

The Utility of Multiple Clinical Variables in Predicting Survival Outcome for Patients with Rectal Cancer: an Integrated Regression and Retrospective Cohort Analysis.

Optimization of Anesthetic Decision-Making in ERAS Using Bayesian Network

Determining Individual Suitability for Neoadjuvant Systemic Therapy in Breast Cancer Patients Through Deep Learning

Risk Stratification of Early-Stage Cervical Cancer with Intermediate-Risk Factors: Model Development and Validation Based on Machine Learning Algorithm

A Risk Stratification Model for Predicting Chemotherapy Benefit in Breast Neuroendocrine Carcinoma: A Population-Based Analysis

Postmenopausal endometrial non-benign lesion risk classification through a clinical parameter-based machine learning model